Elite in Fuchs Dystrophy

Gilles Thuret

Saint-etienne-de-valoux, FR 
Elite in Fuchs Dystrophy
Saint-etienne-de-valoux, FR 
OverviewLocationsClinical Research

Overview

Gilles Thuret practices in Saint-etienne-de-valoux, France. Mr. Thuret is rated as an Elite expert by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Interstitial Keratitis, Corneal Transplant, and Vitrectomy.

His clinical research consists of co-authoring 157 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles and participated in 2 clinical trials in the study of Fuchs Dystrophy.

Gender
Male

Locations

Saint-etienne-de-valoux, France
Other Locations
10, Rue De La Marandière, Saint-priest-la-vetre, 42270, France
Saint Étienne, France
Saint-jean-saint-germain, France
Avenue Albert Raimond, Albert, 42055, France
CHU Grenoble Alpes, Univ. Grenoble Alpes
Grenoble, 38000, France
Paris, France
CHU de Angers
Angers, 49100, France
Saint-etienne, France
Dijon, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa : Study of a Handheld in Vivo Confocal Microscope and of a Fluorescent in Vivo Confocal Microscope
Innovative Imaging of the Conjunctiva, Cornea, and Ocular Adnexa : Study of a Handheld in Vivo Confocal Microscope and of a Fluorescent in Vivo Confocal Microscope
Enrollment Status: Completed
Publish Date: January 08, 2024
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France. The French Fuchs' Follow-up Study, F3S
Analysis of the Genotype/Phenotype Relationship in the Fuchs' Corneal Endothelial Dystrophy in France. The French Fuchs' Follow-up Study, F3S
Enrollment Status: Completed
Publish Date: April 18, 2023
Intervention Type: Biological, Other
Intense Pulsed Light in Meibomian Gland Dysfunctions: Retrospective Study
Intense Pulsed Light in Meibomian Gland Dysfunctions: Retrospective Study
Enrollment Status: Completed
Publish Date: May 13, 2022
Intervention Type: Device
Treatment of Corneal Wounds Emergencies During the COVID-19 Shutdown: Absorbable 10-0 Vicryl Sutures as a Valuable Strategy.
Treatment of Corneal Wounds Emergencies During the COVID-19 Shutdown: Absorbable 10-0 Vicryl Sutures as a Valuable Strategy.
Enrollment Status: Completed
Publish Date: March 29, 2022
Intervention Type: Other
Data Collection of Therapeutic Compliance in Patients Receiving Corneal Graft Using a Collection Box for Corticosteroid Eye Drops
Data Collection of Therapeutic Compliance in Patients Receiving Corneal Graft Using a Collection Box for Corticosteroid Eye Drops
Enrollment Status: Completed
Publish Date: February 16, 2022
Intervention Type: Device
Analysis of the Diagnostic Performance of LacryDiag, a New All-in-one Non-contact Analyzer of the Ocular Surface in the Dry Eye. Study LACRYMOSA
Analysis of the Diagnostic Performance of LacryDiag, a New All-in-one Non-contact Analyzer of the Ocular Surface in the Dry Eye. Study LACRYMOSA
Enrollment Status: Completed
Publish Date: September 09, 2020
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Tolerance to Light for Patients Suffering From Keratitis
Tolerance to Light for Patients Suffering From Keratitis
Enrollment Status: Completed
Publish Date: September 17, 2019
Intervention Type: Device
Study Phase: Not Applicable
Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone: Tolerance and Safety Pilot Study
Immunosuppression During Penetrating Keratoplasty, Using a Subconjunctival Implant Releasing Dexamethasone: Tolerance and Safety Pilot Study
Enrollment Status: Completed
Publish Date: August 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.
Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis.
Enrollment Status: Completed
Publish Date: December 27, 2018
Intervention Type: Procedure
Study Phase: Phase 3
Effect of Neuromuscular Blockade on the Oculomotor by Not Squinting Child
Effect of Neuromuscular Blockade on the Oculomotor by Not Squinting Child
Enrollment Status: Completed
Publish Date: January 25, 2017
Intervention Type: Other
View 9 Less Clinical Trials

157 Total Publications

Tissue-Engineered Endothelial Keratoplasty with Controlled Cell Density: Toward Super TEEKs.
Tissue-Engineered Endothelial Keratoplasty with Controlled Cell Density: Toward Super TEEKs.
Journal: Tissue engineering. Part A
Published: September 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Thuret's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile